Guidelines at a Glance


Condition/Test: Carrier Screening for pregnant women: recommendation that all women be offered expanded carrier screening prior to pregnancy
Source: American College of Obstetricians and Gynecologists’ Committee on Genetics
Date: March 2017

Condition/Test: Castleman Disease: diagnostic criteria
Source: CDCN working group/international symposium
Date: March 2017

Condition/Test: Colerectal Cancer—molecular testing: evidence based recommendations for mutational testing of EGFR signalling pathways for patients with colorectal cancer and steps to operationalize CRC molecular testing
Source: ASCP, CAP, AMP, ASCO
Date: March 2017

Condition/Test: Colorectal cancer testing: guidelines for screening/use of Cologuard test
Source: National Committee for Quality Assurance Hedis
Date: 2017 edition of Healthcare Effectiveness Data and Information Set (HEDIS)

Condition/Test: Liver chemistry—practice guideline to define health serum alanine aminotransferase (ALT) Level
Source: American College of Gastroenterology
Date: Dec. 2016

Condition/Test: Tuberculosis: recommendation for testing of patients at risk of TB infection
Source: American Thoracic Society, Infectious Diseases Society of America, and the U.S. Centers for Disease Control and Prevention (CDC)
Date: Dec. 2016

Condition/Test: Genital Herpes Screening – UPDATE-no screening for asymptomatic pregnant women
Source: USPSTF (published in JAMA)
Date: Dec. 20, 2016

Condition/Test: Molecular colorectal cancer (CRC): screening—guidelines for screening
Source: U.S. Preventive Services Task Force (USPSTF)
Date: June 2016

Condition/Test: Bone Marrow Testing: practice guidelines for reporting clinical findings
Source: College of American Pathologists
Date: 2016

Condition/Test: Cardiovascular disease: guideline on assessment of cardiovascular risk
See also: http://circ.ahajournals.org/content/129/25_suppl_2/S49
Source: American College of Cardiology and American Heart Association
Date: June 2014

Condition/Test: Lung cancer: evidence-based guidleines for lung cancer testing and for validation of whole slide imaging.
See also: https://www.iaslc.org/articles/cap-iaslc-amp-molecular-testing-guideline
Source: CPA, AMP and International Association for the Study of Lung Cancer
Date: April 2013

You need to have an account to access this content.

Please Login...

Email Address

Password

or Register for free for a Limited Access account.

Email Address


(-0000g2)